JONATHAN SADEH, MD
Osteopathic Medicine at 43 St, New York, NY
License number
New York 157884
Category
Osteopathic Medicine
Type
Emergency Medicine
Address
Address
500 W 43Rd St, New York, NY 10036
Phone
(212) 594-6340
Personal information
See more information about JONATHAN SADEH at radaris.comName
Address
Phone
425 W End Ave APT 4A, New York, NY 10024
425 End Ave, New York, NY 10024
500 43Rd St, New York, NY 10036
500 43Rd St, New York, NY 10036
425 W End Ave, New York, NY 10024
Organization information
See more information about JONATHAN SADEH at bizstanding.comJonathan Sadeh MD
645 10 Ave, New York, NY 10036
Industry:
Emergency Medicine, Internist
Phone:
(212) 484-5800 (Phone)
Jonathan S. Sadeh
Professional information
Jonathan S Sadeh, New York NY
Specialties:
Emergency Medicine, Internal Medicine
Work:
Ryon Chelsea Clinton Community Center
645 10Th Ave, New York, NY 10036
645 10Th Ave, New York, NY 10036
Education:
New York University - Mount Sinai (1996)
Dr. Jonathan Sadeh, New York NY - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
645 10Th Ave, New York 10036
(212) 265-4500 (Phone), (212) 531-7514 (Fax)
500 W 43Rd St SUITE 15B, New York 10036
(212) 594-6340 (Phone)
(212) 265-4500 (Phone), (212) 531-7514 (Fax)
500 W 43Rd St SUITE 15B, New York 10036
(212) 594-6340 (Phone)
Certifications:
Internal Medicine, 1999
Awards:
Healthgrades Honor Roll
Languages:
English, Hebrew
Education:
Medical School
Mount Sinai School of Medicine
Graduated: 1996
Boston Medical Center
Boston U-Boston Med Ctr
Mount Sinai School of Medicine
Graduated: 1996
Boston Medical Center
Boston U-Boston Med Ctr
Methods Of Treating Copd
US Patent:
2011000, Jan 13, 2011
Filed:
Dec 3, 2008
Appl. No.:
12/746232
Inventors:
Irina V. Khanskaya - Morristown NJ, US
Jonathan Sadeh - New York NY, US
Heribeth Staudinger - Green Brook NJ, US
Jonathan Sadeh - New York NY, US
Heribeth Staudinger - Green Brook NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 31/366, A61K 31/341, A61P 11/00
US Classification:
514460, 514471
Abstract:
Disclosed is a method of treating chronic obstructive disease, said method comprising administering an effective amount of a CXCR2 antagonist and administering an effective amount of at least one drug selected from the group consisting of: angiotensin-converting enzyme inhibitors, Angiotensin II receptor antagonists, cardioselective beta blockers, and lipid regulating drugs. Examples of the CXCR2 antagonist include: (formula 1.0A and 1.0B).